Adjuvant anthracyclines and taxanes: quantifying the costs of therapeutic advances in breast cancer.
Morris
Patrick G
PG
Bach
Peter B
PB
D018943:Anthracyclines / Q000191:economics* / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000191:economics / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000191:economics* / Q000453:epidemiology; D017024:Chemotherapy, Adjuvant / Q000191:economics* / Q000706:statistics & numerical data; D005260:Female; D005858:Germany / Q000453:epidemiology; D017048:Health Care Costs / Q000706:statistics & numerical data; D006801:Humans; D015995:Prevalence; D043823:Taxoids / Q000191:economics* / Q000627:therapeutic use*
D018943:Anthracyclines; D000970:Antineoplastic Agents; D043823:Taxoids